Antibody · HER2

AntibodystaleMerckPhase 2

효능 ORR 11.5%임상시험 15상태 RECRUITING

pembrolizumab (Keytruda, SD-101 + Pembrolizumab)

Breast Neoplasms; Breast Cancer · HER2

AntibodystaleRegeneronPhase 2

효능 ORR 3.2%임상시험 4상태 RECRUITING

VV1 + Cemiplimab (VV1 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

AntibodystaleRochePhase 2

임상시험 4상태 RECRUITING

trastuzumab (Herceptin, AMG 386 and Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

AntibodystaleRochePhase 3

HLX87 + Pertuzumab (HLX87 + Pertuzumab)

HER2 + Breast Cancer · HER2

#HER2#Antibody#Phase3#항체#면역항체+3

AntibodystaleRochePhase 2

trastuzumab (Herceptin, MK-2206 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

AntibodystaleMargaret Gatti-MaysPhase 2

Naxitamab (Naxitamab)

Anatomic Stage IV Breast Cancer AJCC v8; HER2-Negative Breast Carcinoma · HER2

AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

trastuzumab (Herceptin, AMG 386 with or without Trastuzumab)

Breast Neoplasms; Breast Cancer · HER2

AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

ARX788 + Cemiplimab (ARX788 + Cemiplimab)

Breast Neoplasms; Breast Cancer · HER2

AntibodyBiologicstaleNational Cancer Institute (NCI)Phase 1

Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor, Adenoviral Transduced Autologous Human Epidermal Growth Factor Receptor (AdHER)2/neu Dendritic Cell (DC) Vaccine)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4

임상시험 1상태 ACTIVE

AntibodystaleFudan UniversityPhase 2

Carrelizumab (Carrelizumab)

Breast Neoplasm; Breast Cancer · HER2

AntibodystaleBaptist Health South FloridaPhase 1

trastuzumab (Herceptin, Combined use of SRS with Tucatinib, Trastuzumab, and Capecitabine)

Brain Metastases; HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4

임상시험 1상태 DISCONTINUED

AntibodystaleHenan Cancer HospitalPhase 3

trastuzumab (Herceptin, Docetaxel+ carboplatin+ trastuzumab + patuzumab)

Breast Cancer,HER2-positive · HER2

#HER2#Antibody#Phase3#항체#면역항체+4

AntibodystaleNektar TherapeuticsPhase 2

nivolumab (Opdivo, Dose Escalation Doublet: Combination of NKTR-214 + nivolumab)

Melanoma; Renal Cell Carcinoma · HER2

AntibodystaleNektar TherapeuticsPhase 2

효능 ORR 64%임상시험 1상태 ACTIVE

nivolumab (Opdivo, Dose Expansion Doublet: Combination of NKTR-214 + nivolumab)

Melanoma; Renal Cell Carcinoma · HER2

AntibodystaleNektar TherapeuticsPhase 2

효능 ORR 64%임상시험 1상태 ACTIVE

nivolumab (Opdivo, Dose Expansion Triplet: Combination of NKTR-214+ nivolumab+ ipilimumab)

Melanoma; Renal Cell Carcinoma · HER2

AntibodystaleTianjin Medical University Canc…Preclinical

효능 ORR 64%임상시험 1상태 ACTIVE

Enituzumab injection+Abesili tablets+Anastrozole tablets (Enituzumab injection+Abesili tablets+Anastrozole tablets)

Advanced HR+ HER2 Negative Breast Carcinoma · HER2

#HER2#Antibody#Preclinical#항체#면역항체+3

임상시험 1상태 ACTIVE

AntibodystaleRochePhase 3

FEC-T+Pertuzumab (FEC-T+Pertuzumab)

Breast Cancer; HER2 Positive · HER2

#HER2#Antibody#Phase3#항체#면역항체+4

AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

GSK 5733584 + Dostarlimab (GSK 5733584 + Dostarlimab)

Breast Neoplasms; Breast Cancer · HER2